ARCHIVES

FDA Grants Priority Review To Two Drugs in NSCLC

This article is from The Cancer Letter archive.

Vol. 36 No. 2 | February 22, 2013

Download PDF Visit The Full Archive

Related Articles

Phase III Nexavar Trial Fails Primary Endpoint

August 29, 2014

NCI Will Encourage More Nutrition Research, Upton Tells McGovern

June 23, 1978

ODAC Votes 13:0 For Approving Perjeta

September 27, 2013

Organ Systems Program to Submit 10 More Concepts In Fall

July 10, 1987

In Brief: Bresnick Directs Norris Cotton Cancer Center; FASEB Honors Kirschstein; Van Nevel’s 2th Year

February 5, 1993

In Brief: HHS Drags Feet, NCI Considering Contract To Review Cancer Research Facility Needs

October 14, 1983